Recording of Discussion 18: The Value Imperative for the Pharmaceutical Industry
Those launching new pharmaceutical brands face a different landscape of payers and customers, requiring commercial strategies that show the value of the product. The current pressure on healthcare costs creates a unique imperative to embrace value-based solutions. On July 16th, Andrew Croshaw, Jeremy Bahr, and Leavitt Partners advisor Prem Kumar discussed how value in pharmaceuticals can (and must) be a successful strategy. A recording of the discussion can be found below. Follow our company LinkedIn page to join the live broadcasts, and review upcoming topics and speakers here!